MKC — McCormick & Company, Incorporated

Sentiment is unambiguously negative. The shares fell 6.8% in the week after the print, 17.0% over the trailing month and 16.4% over three months, and sell-side targets were cut (UBS $52→$48, Bernstein $68→$59, Stifel at $48). Management reaffirming rather than raising FY26 guidance removed the one catalyst bulls were waiting for, and the market is focused on soft U.S. consumer volumes, reinvestment needs, packaging supply friction and merger overhead rather than the adjusted beat. Consensus is a lukewarm 'Hold' (10 buy / 18 hold / 2 sell, $53.50 average target), which tells you even the bulls are not aggressively defending the name at these levels.

Reported revenue growth has inflected sharply — from +0.2%/+1.0%/+2.7% YoY in Q1/Q2/Q3 FY25 to +16.7%/+16.7%/+17.4% in Q1/Q2/Q3 FY26 — but essentially all of that is the consolidation of the McCormick de Mexico acquisition, with organic growth of only +1.9%. Margins are the genuinely improving line item: gross margin expanded ~190bps YoY to 39.3% in Q3 FY26 (from 37.4%) and operating margin rose to 18.1% from 16.7% on CCI productivity. Reported earnings are the noise: Q3 FY26 net income fell 56.7% YoY to $97.6M (EPS $0.36) on $141.5M of charges including a Malaysia pepper-project impairment, while Q1 FY26 net income of $1,016.2M (EPS $3.77, a ~54% net margin) was inflated by a one-time gain tied to the de Mexico consolidation. Net read: modest organic growth, real gross-margin expansion, and reported EPS that is close to useless as a trend signal.

As of 2026-10-04 the headline 8.06x TTM P/E is a mirage — TTM EPS of $5.572 carries a ~$1.0B one-time Q1 FY26 gain — and the 0.088 PEG is meaningless for the same reason. The numbers that matter: 14.5x forward earnings ($44.67 / $3.089), 1.72x book, 1.56x sales and ~10.9x EV/EBITDA, with a 3.65% dividend yield per FMP data (the research brief cites >4.3%). Against its own history MKC is cheap — 5-year average P/E 27.7x and average P/S 3.12x versus 1.56x today — but against packaged-food peers trading around 11–13x forward earnings it is only roughly in line to modestly cheap. Verdict: cheap versus its own history, fair versus the peer group.

The gap between headline and underlying earnings is the entire story. Q3 FY26 printed $0.36 reported versus $0.86 adjusted — a $0.50 swing from charges — while the $5.572 TTM EPS behind the eye-catching 8.1x P/E is itself inflated by the Q1 one-time gain. On any clean number MKC trades near 14–15x forward EPS of $3.089, i.e. the market is pricing a permanently low-growth staples business with no credit for a turn. That makes the setup event-driven rather than multiple-driven: with organic growth at 1.9% and guidance merely reaffirmed there is little left in the price to punish further disappointment, but a real organic-volume inflection, an input-cost break, or clarity that the Unilever Foods combination is accretive could re-rate the multiple toward the mid-to-high teens staples historically commanded. The market is currently underwriting the pessimistic path.

As of 2026-10-04 the tape is broken rather than merely weak: RSI(14) at 25.08 (deeply oversold), price 9.01% below the 20-day SMA, 13.57% below the 50-day and 19.52% below the 200-day, with returns of -6.82% (1 week), -16.97% (1 month) and -16.43% (3 months). At $44.67 the stock sits just above the 52-week low of $43.25. A name this far below its 200-day is prone to violent reflex bounces, but oversold is not a base — there is no higher low and no evidence of accumulation. Timing implication: this is a knife-catch until price reclaims at least the 20-day SMA and stops printing lower lows; waiting for stabilization or a catalyst beats buying the RSI print alone.

• Consumer-staples volume fatigue: budget-constrained U.S. shoppers are trading down and QSR traffic is choppy, pressuring both the Consumer segment and the Flavor Solutions restaurant channel.
• Input-cost and supply-chain inflation across freight, packaging and commodities (including pepper), with geopolitically driven disruptions such as the Middle East conflict feeding recurring cost volatility.
• Pending M&A and regulatory review of the combination with Unilever's Foods business — timing, terms and any remedies sit outside management's control and consume capital and bandwidth in the interim.
• Defensive-sector rotation and rates: MKC's low beta (0.634) makes it a bond-proxy staple, so it competes with the risk-free yield; higher rates cap multiple expansion even as the 3.65% dividend attracts income buyers.
• FX and international exposure: a meaningful share of sales sits outside the U.S., so dollar strength is a persistent headwind to reported revenue and earnings.

• Regulatory milestones and any disclosure of terms/synergy targets on the pending Unilever Foods combination — the single biggest swing factor in the equity story.
• Q4 FY26 results and FY27 guidance (next report estimated 2027-01-21), including any sign of a guidance raise or organic-volume inflection.
• U.S. Consumer segment volume recovery and holiday-season promotional execution.
• Further gross-margin expansion from the CCI productivity program and any easing of commodity/freight costs.
• Continued dividend growth — with roughly 2x free-cash-flow coverage, MKC can keep raising the payout even in a soft tape.

• Organic growth stays stuck near 2%: the M&A-driven headline masks a business that is barely growing on its own.
• Merger integration and overhang: the Unilever Foods combination drains management bandwidth and near-term capital and could disappoint on synergies or terms.
• Balance sheet: a 0.657 current ratio and $2.906B of long-term debt leave little cushion, leverage could rise through integration, and 7.9% ROIC is already below cost of capital.
• Recurring 'one-time' charges: Q3 FY26's $141.5M (transaction costs plus the Malaysia pepper impairment) follows a pattern that keeps depressing reported earnings and muddying the story.
• Value-trap risk: the discount to MKC's own five-year average multiples (27.7x P/E, 3.12x P/S) may reflect a permanent de-rating of packaged-food valuations rather than a temporary dislocation.

This is not a buy to chase here. McCormick owns a genuinely strong brand portfolio (French's, Frank's RedHot, Old Bay), earns 39% gross margins with expanding profitability, generates about $907M of TTM free cash flow (~7.5% yield) that comfortably covers a 3.65% dividend, and trades at 14.5x forward EPS versus a 27.7x five-year average. But the business is growing organically at only ~1.9%, earns 7.9% ROIC, runs a current ratio of 0.657, and is mid-way through a transformative, unquantified merger while management merely reaffirmed guidance. Cheap-for-a-reason is the more defensible read until organic volumes turn or the Unilever combination is de-risked.

Blended two independent approaches as of 2026-10-04: (1) 16.0x forward EPS of $3.089 — a discount to MKC's 5-year average 27.7x P/E and only a modest premium to branded packaged-food peers, justified by ~2% organic growth and 7.9% ROIC — which yields $49.4; and (2) a 6.0% required free-cash-flow yield on ~$825M of normalized FCF (between FY25's ~$708M and the ~$907M TTM that already includes de Mexico), which yields ~$51.2 per share on 268.9M shares. Averaging the two gives ~$50, roughly 12% above the $44.67 price and below the $53.50 analyst consensus.